Globe Life (NYSE:GL) Issues FY 2026 Earnings Guidance

Globe Life (NYSE:GL) updated its FY 2026 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 15.350-15.650 for the period, compared to the consensus EPS estimate of 15.720. Globe Life also updated its FY 2027 guidance to 16.100-17.100 EPS.

Wall Street Analyst Weigh In

GL has been the subject of several recent analyst reports. Piper Sandler cut Globe Life from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $200.00 to $165.00 in a report on Friday. TD Cowen cut their price objective on shares of Globe Life from $225.00 to $215.00 and set a “buy” rating on the stock in a report on Friday. UBS Group set a $165.00 target price on shares of Globe Life in a research report on Friday. Jefferies Financial Group boosted their target price on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a report on Friday, July 10th. Finally, Morgan Stanley decreased their price target on shares of Globe Life from $208.00 to $197.00 and set an “overweight” rating on the stock in a report on Monday, October 5th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $182.60.

Globe Life Trading Down 8.2%

Shares of Globe Life stock traded down $13.79 during trading hours on Friday, hitting $154.62. The company’s stock had a trading volume of 1,651,226 shares, compared to its average volume of 505,383. Globe Life has a 1-year low of $127.85 and a 1-year high of $191.55. The business has a fifty day moving average of $169.95 and a 200 day moving average of $167.16. The company has a market capitalization of $11.88 billion, a PE ratio of 10.34 and a beta of 0.44. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, October 21st. The company reported $4.84 EPS for the quarter, missing analysts’ consensus estimates of $4.90 by ($0.06). Globe Life had a net margin of 18.89% and a return on equity of 19.95%. The business had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the prior year, the business posted $4.81 EPS. The business’s revenue was up 5.5% on a year-over-year basis. As a group, equities analysts forecast that Globe Life will post 15.65 EPS for the current year.

Globe Life Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, October 5th. Globe Life’s payout ratio is currently 8.76%.

Globe Life declared that its Board of Directors has approved a share buyback program on Monday, August 10th that authorizes the company to buy back $2.50 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 17.7% of its shares through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

Insider Buying and Selling

In other news, EVP Robert Hensley sold 10,000 shares of the company’s stock in a transaction dated Tuesday, September 22nd. The stock was sold at an average price of $170.07, for a total value of $1,700,700.00. Following the completion of the sale, the executive vice president owned 12,384 shares of the company’s stock, valued at $2,106,146.88. This represents a 44.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael Majors sold 37,000 shares of the stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total value of $6,609,680.00. Following the completion of the sale, the executive vice president owned 53,518 shares of the company’s stock, valued at approximately $9,560,455.52. This trade represents a 40.88% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 143,650 shares of company stock worth $25,793,717 over the last three months. 2.11% of the stock is currently owned by corporate insiders.

More Globe Life News

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life projected 2027 adjusted earnings of $16.10–$17.10 per share, with the midpoint modestly above the current consensus estimate of $16.51. Management also targeted $850 million–$950 million in parent excess cash flow, supporting potential capital returns. Globe Life projects 2027 EPS and excess cash flow
• Positive Sentiment: TD Cowen maintained a Buy rating, although it reduced its price target from $225 to $215. The revised target still implies substantial potential upside based on the referenced share price. TD Cowen price target update
• Neutral Sentiment: Management’s 2027 EPS guidance range spans $16.10–$17.10, indicating continued growth potential but also a relatively wide range of outcomes. The company’s quarterly revenue and investment income benefited from growth in premiums and investments. Globe Life earnings guidance
• Negative Sentiment: Globe Life reported third-quarter EPS of $4.84, below analyst expectations near $4.87–$4.90. Weaker underwriting income, rising expenses and a reported $6.4 million underwriting loss offset higher premiums and investment income. Globe Life Q3 earnings miss
• Negative Sentiment: Globe Life lowered its 2026 EPS guidance to $15.35–$15.65, below the $15.72 consensus estimate. The weaker outlook was linked in part to losses at Evry Health, increasing concerns about profitability and execution. Evry Health losses and Globe Life guidance
• Negative Sentiment: Piper Sandler downgraded Globe Life, arguing that the stock is no longer a “predictable safe haven” following the earnings release. The downgrade adds pressure to investor sentiment after the earnings miss and guidance reduction. Piper Sandler downgrades Globe Life

About Globe Life

Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.